within Pharmacolibrary.Drugs.ATC.S;

model S03AA06
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 1.1666666666666668e-06,
    adminDuration  = 600,
    adminMass      = 80 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.00017999999999999998,
    k12             = 0.12,
    k21             = 0.12
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S03AA06</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Gentamicin is an aminoglycoside antibiotic primarily used for the treatment of serious Gram-negative bacterial infections. It acts by inhibiting bacterial protein synthesis. While its systemic use is approved and common, the ATC code S03AA06 refers to gentamicin for ophthalmic use in the treatment of eye infections such as conjunctivitis and blepharitis.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for adult patients, receiving intravenous administration for systemic infections. Ophthalmic absorption is minimal and systemic exposure is generally considered negligible; therefore, the PK model is based on IV data in adults.</p><h4>References</h4><ol><li><p>Boisson, M, et al., &amp; Grégoire, N (2018). Pharmacokinetics of intravenous and nebulized gentamicin in critically ill patients. <i>The Journal of antimicrobial chemotherapy</i> 73(10) 2830–2837. DOI:<a href=\"https://doi.org/10.1093/jac/dky239\">10.1093/jac/dky239</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29947799/\">https://pubmed.ncbi.nlm.nih.gov/29947799</a></p></li><li><p>Gestrich, A, et al., &amp; Zaghloul, I (2018). Pharmacokinetics of intravenous gentamicin in healthy young-adult compared to aged alpacas. <i>Journal of veterinary pharmacology and therapeutics</i> 41(4) 581–587. DOI:<a href=\"https://doi.org/10.1111/jvp.12506\">10.1111/jvp.12506</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29761517/\">https://pubmed.ncbi.nlm.nih.gov/29761517</a></p></li><li><p>Steinman, A, et al., &amp; Soback, S (2002). Pharmacokinetics of gentamicin C1, C1a and C2 in horses after single intravenous dose. <i>Equine veterinary journal</i> 34(6) 615–618. DOI:<a href=\"https://doi.org/10.2746/042516402776180160\">10.2746/042516402776180160</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12358003/\">https://pubmed.ncbi.nlm.nih.gov/12358003</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S03AA06;
